Status:
COMPLETED
WeExPAnd: PrEP Demonstration Project Among Women at Risk for HIV Infection - Preexposure Prophylaxis (PrEP)
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Conditions:
HIV-infection/AIDS
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The objective of this application is to increase PrEP uptake among women vulnerable to HIV acquisition in the rural South, specifically those seeking care at Federally Qualified Healthcare Centers (FQ...
Detailed Description
Investigators completed formative qualitative research to explore the HIV risk perceptions of African American or Black (AA) women with recent PrEP use, AA women who are candidates for PrEP, and provi...
Eligibility Criteria
Inclusion
- Inclusion/Exclusion Criteria
- Patients
- HIV-uninfected women
- Age 18 years or older
- English speaking
- Report sexual activity or anticipate sexual activity within 6 months
Exclusion
Key Trial Info
Start Date :
March 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT04373551
Start Date
March 7 2022
End Date
June 30 2024
Last Update
December 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294